Literature DB >> 3319594

Pathology of pituitary tumors.

K Kovacs1, E Horvath.   

Abstract

This article reviewed the classification, morphologic features, and pathogenesis of human hypophyseal adenomas and differences between hyperplasia and adenoma. Histologic, immunohistochemical, and electron microscopic investigation obtained a deeper insight into several aspects of pituitary cytopathology. Based on these studies, a meaningful classification has been developed that separates hypophyseal adenomas into distinct entities. It hinges on histology, hormone content, ultrastructural characteristics, cellular composition, and cytogenesis and correlates the morphologic features of adenoma cells with endocrine activity. Although progress has been spectacular during the last two decades in the better understanding of structural characteristics and hormonal function of pituitary adenomas, much more work is necessary to shed light on structure-function correlations and pathogenesis. Collaborative investigations between clinical investigators and basic scientists can further advance knowledge in this intriguing and important field.

Entities:  

Mesh:

Year:  1987        PMID: 3319594

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  18 in total

Review 1.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 2.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

3.  Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain.

Authors:  D Spengler; M Villalba; A Hoffmann; C Pantaloni; S Houssami; J Bockaert; L Journot
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

Review 4.  Medical management of growth hormone-secreting pituitary adenomas.

Authors:  Michael S Racine; Ariel L Barkan
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

5.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

6.  Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.

Authors:  G Cennamo; R S Auriemma; D Cardone; L F S Grasso; N Velotti; C Simeoli; C Di Somma; R Pivonello; A Colao; G de Crecchio
Journal:  Eye (Lond)       Date:  2015-03-27       Impact factor: 3.775

7.  Pituitary Adenomas.

Authors:  Grant T. Liu
Journal:  Curr Treat Options Neurol       Date:  2002-07       Impact factor: 3.598

Review 8.  The evaluation and management of subclinical pituitary disease.

Authors:  S G Soule; H S Jacobs
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

9.  Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.

Authors:  J Li; L Stefaneanu; K Kovacs; E Horvath; H S Smyth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 10.  Somatostatin analogs in medical treatment of acromegaly.

Authors:  Michael S Racine; Ariel L Barkan
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.